We screened for Nasdaq-listed stocks that have held up well relative to the overall index but still look cheap relative to their estimated earnings growth potential.
Right now there are tremendous opportunities in healthcare that will come to fruition in the next decade that you can buy at cheap valuations because the market overall is weak, and no one knows how Obamacare will unfold.